New Delhi: The Division of Prescribed drugs (DoP) has invited business feedback on proposed additions and deletions within the current list of medical gadgets exempted from World Tender Enquiry (GTE) for public procurement of merchandise that aren’t manufactured in India.
The revision course of of the present list of 354 medical gadgets started in February this 12 months, when device producers submitted proposals for additions and deletions. The representations are open for public feedback and objections till July 15 to finalize the revisions.
The division has acquired representations for the inclusion of 350 gadgets akin to epidural anaesthesia kits, bedside ultrasound methods, multi-modal vacuum wound therapeutic methods, and 1.5 Tesla MRI scanners, amongst others.
Stakeholders have additionally requested, exclusion of 235 merchandise, together with digital subtraction angiography methods, intraoperative radiotherapy machines, surgical navigation methods and so forth., citing rising capital dedication and enchancment in home manufacturing of such merchandise.
Underneath the Make in India push, the federal government mandated public businesses to prioritize regionally produced medical gadgets primarily based on the calculation of native content material. Nonetheless, in 2024 for merchandise not produced domestically, the Finance Ministry allowing procurement of choose gadgets from abroad suppliers, for tenders as much as Rs 200 crore.
“The 2024 train was largely complete, a couple of superior applied sciences that aren’t manufactured in India have been missed out within the exemption list. We welcome the present evaluation and hope it leads to an entire, evidence-based framework that precisely displays manufacturing realities and affected person wants,” stated Pavan Choudary, Chairman of multinational device makers business physique, MTaI.
Talking for home producers, Rajiv Nath, Discussion board Coordinator, AiMeD referred to as for, “earmarking a share of public procurement” for merchandise the place corporations have already taken take a look at licenses, dedicated capital expenditure, or launched manufacturing however are but to finish the three‑12 months market standing requirement.
Nath argued that, acquiring manufacturing approval for high-risk merchandise —Class C and D — takes as much as “9–15 months” and through this gestation interval, corporations wrestle to service capital financing and stuck prices with out gross sales income.
At present, India has a high-import dependency within the medical gadgets sector and round 80-85 per cent of whole device requirement is met by means of imports. In FY26, imports surged 17 per cent year-on-year to Rs 89,000 crore, largely pushed by high-risk, technology-intensive merchandise.
Source link
#Centre #seeks #Industry #feedback #revision #GTEExempt #Medical #device #list
